Clinical Trials Browser

INDUSTRY × Cetuximab × Plasma cell × Clear all

NCT01524978 2017-11-20

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Phase 2 Completed

208 enrolled 26 charts

Multiple Myeloma, Neoplasms